Detalhe da pesquisa
1.
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.
Cell
; 187(3): 596-608.e17, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194966
2.
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.
Cell
; 185(3): 447-456.e11, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35026151
3.
Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination.
Emerg Infect Dis
; 28(4): 743-750, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35203113
4.
Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy.
HIV Med
; 23(5): 558-563, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34725907
5.
Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade.
Oncology
; 100(7): 392-398, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35609553
6.
SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study.
BMC Infect Dis
; 22(1): 403, 2022 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35468758
7.
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant.
Int J Mol Sci
; 23(22)2022 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36430535
8.
[Care of rheumatology patients during the lockdown in early 2020 : Telemedicine, delegation, patient satisfaction and vaccination behavior]. / Versorgung von rheumatologischen Patienten während des Lockdowns im Frühjahr 2020 : Telemedizin, Delegation, Patientenzufriedenheit und Impfverhalten.
Z Rheumatol
; 81(2): 157-163, 2022 Mar.
Artigo
em Alemão
| MEDLINE | ID: mdl-33974131
9.
Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination.
Clin Infect Dis
; 73(11): 2000-2008, 2021 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34134134
10.
Perceived versus proven SARS-CoV-2-specific immune responses in health-care professionals.
Infection
; 48(4): 631-634, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32524515
11.
SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination.
Lancet
; 398(10305): 1041-1042, 2021 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416198
12.
Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine.
EBioMedicine
; 99: 104947, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38160529
13.
Migrant healthcare workers during COVID-19: bringing an intersectional health system-related approach into pandemic protection. A German case study.
Front Public Health
; 11: 1152862, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533524
14.
Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals.
Front Immunol
; 14: 1166589, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37215123
15.
Healthcare Workers' Perceptions and Medically Approved COVID-19 Infection Risk: Understanding the Mental Health Dimension of the Pandemic. A German Hospital Case Study.
Front Public Health
; 10: 898840, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35669735
16.
The Impact of COVID-19 Vaccination on the Social Participation of Immunocompromised Persons - Results of a Multicenter Observational Study.
Front Public Health
; 10: 877623, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35757603
17.
Long-term Consequences of COVID-19 and the Pandemic: Protocol for a Web-Based, Longitudinal Observational Study (DEFEAT).
JMIR Res Protoc
; 11(10): e38718, 2022 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108134
18.
Host Cell Entry and Neutralization Sensitivity of SARS-CoV-2 Lineages B.1.620 and R.1.
Viruses
; 14(11)2022 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36366573
19.
SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination.
Cell Rep
; 39(5): 110754, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477025
20.
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies.
Cell Host Microbe
; 30(8): 1103-1111.e6, 2022 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35588741